BTAIVSSNGX• 6 Months (Normalized)
BTAI vs SNGX (BioXcel Therapeutics Inc. vs Soligenix Inc.)
Showing Closing Date Range from Mar, 15 to Sep, 11, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BTAI Performance $0.05
-96.69%
BioXcel Therapeutics Inc.
Normalized Baseline0.00%
SNGX Performance $0.36
-70.73%
Soligenix Inc.
Normalized Baseline0.00%
Alpha Spread Margin SNGX LEADS
-25.96%
SNGX outperforming by 25.96%
BTAISNGX
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BTAI SNGX
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(125 dates)
| Date | BTAI Price | BTAI Gain (%) | SNGX Price | SNGX Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 11, 2026 | $0.05 | -96.69% | $0.36 | -70.73% | -25.96% |
| Sep 10, 2026 | $0.05 | -96.75% | $0.36 | -70.73% | -26.02% |
| Sep 09, 2026 | $0.05 | -96.95% | $0.37 | -69.92% | -27.03% |
| Sep 08, 2026 | $0.04 | -97.21% | $0.38 | -69.11% | -28.10% |
| Sep 04, 2026 | $0.07 | -95.19% | $0.38 | -69.11% | -26.08% |
| Sep 03, 2026 | $0.12 | -92.34% | $0.38 | -69.11% | -23.23% |
| Sep 02, 2026 | $0.11 | -93.05% | $0.38 | -69.11% | -23.94% |
| Sep 01, 2026 | $0.14 | -91.10% | $0.38 | -69.11% | -21.99% |
| Aug 31, 2026 | $0.16 | -89.42% | $0.38 | -69.11% | -20.31% |
| Aug 28, 2026 | $0.18 | -88.25% | $0.38 | -69.11% | -19.14% |
| Aug 27, 2026 | $0.72 | -53.31% | $0.38 | -69.11% | +15.80% |
| Aug 26, 2026 | $0.78 | -49.35% | $0.38 | -69.11% | +19.76% |
| Aug 25, 2026 | $0.74 | -51.82% | $0.41 | -66.67% | +14.85% |
| Aug 24, 2026 | $0.76 | -50.58% | $0.40 | -67.48% | +16.90% |
| Aug 21, 2026 | $0.80 | -47.79% | $0.40 | -67.48% | +19.69% |
Page 1 of 9